Optimising Type 2 Diabetes Outcomes through Dapagliflozin and Sitagliptin FDC: A Gluco-Cardio-Renal Perspective Dr. Mayur Agrawal27 Nov 2025 11:15 AM ISTType 2 Diabetes (T2D) is a major public health challenge, with India ranking second globally in prevalence. [1] The coexistence of diabetes,...
WHO Issues First Global Guideline on Diabetes in Pregnancy on World Diabetes Day 2025: Key Takeaways Dr. Kamal Kant Kohli26 Nov 2025 12:15 PM ISTThe World Health Organization (WHO) has issued its first global guideline for diabetes in pregnancy on World Diabetes Day (November 14, 2025), and the...
PRIME-Vilda Trial Results Highlights Vildagliptin SR's Efficacy and Safety in Indian Type 2 Diabetes Patients on Metformin Deeksha Bhandari25 Nov 2025 12:40 PM ISTThe study evaluates the efficacy and safety of once-daily Vildagliptin SR 100 mg vs Sitagliptin 100 mg in type 2 diabetes patients inadequately...
Real-World Evidence in Psoriatic Arthritis: PRO-SPIRIT Study Dr. Garima Soni25 Nov 2025 11:45 AM ISTIn the video, Dr. Nicola J. Gullick, a Consultant Rheumatologist in Coventry and one of the investigators on the PRO-SPIRIT study, provides an...
Explainer Video: Acknowledge- Assisting Patients Through Challenges in Their Diabetes Care Journey Deeksha Bhandari22 Nov 2025 12:01 PM IST Weight management is an important but challenging part of type 2 diabetes care, especially for people with overweight or obesity. Even...
Effect of Micronized Purified Flavonoid Fraction (MPFF) in Indian patients with Grade I-II Hemorrhoids: the IMPACT HD Study Dr. Garima Soni20 Nov 2025 10:30 AM ISTA recently published IMPACT-HD (Integrating Proctoscopic Assessment With Patient Experience of Micronized Purified Flavonoid Fraction in Treatment...
Gliclazide - Revisiting a Preferred Sulphonylurea in 2025 - Dr Silima Tarenia and Dr Shehzad Ruman Deeksha Bhandari13 Nov 2025 6:00 PM ISTOn this World Diabetes Day, we bring you a special episode of Dia Dialogues titled "Gliclazide - Revisiting a Preferred Sulphonylurea in 2025." ...
Aspirin in Obese T2D with Atherogenic Dyslipidemia: Identifying the Ideal Candidates Dr. Srinivas Kudva12 Nov 2025 12:00 PM ISTIndia faces a rapidly escalating triple syndemic of obesity, type 2 diabetes (T2D), and atherogenic dyslipidemia, conditions that frequently overlap...
Explainer video: Advise- Educating Patients about Addressing Glycemic and Weight Goals Deeksha Bhandari11 Nov 2025 11:45 AM ISTTalking about excess weight with people living with type 2 diabetes can be sensitive, but it is an important part of diabetes care. Evidence shows...
Risk Beyond Control: Inherited and Causal CV Risk Factors and the Role of Aspirin Dr. Prakash Kumar11 Nov 2025 11:30 AM ISTCardiovascular diseases (CVDs) are the leading cause of non-communicable disease (NCD) deaths in India, accounting for nearly 48% of all NCD...
Long-Acting Relief in Allergic Rhinitis: A Clinical Update on Dual Molecule Approach Dr. Kamal Kant Kohli10 Nov 2025 10:58 AM ISTAllergic rhinitis (AR) is a pervasive health burden affecting over 400 million individuals globally, presenting with a wide range of nasal symptoms...
H2 receptor antagonists (H2RAs) in Gastrointestinal Care of Neonates and Infants: Indian Paediatricians' Perspectives Dr. Garima Soni8 Nov 2025 11:50 AM ISTGastrointestinal (GI) conditions are common in neonates and infants. These may include Gastroesophageal Reflux (GER), Gastroesophageal Reflux...
